Biosyent Inc banner

Biosyent Inc
XTSX:RX

Watchlist Manager
Biosyent Inc Logo
Biosyent Inc
XTSX:RX
Watchlist
Price: 14.75 CAD 0.07%
Market Cap: CA$171.2m

Intrinsic Value

The intrinsic value for Biosyent Inc (RX) under the Base Case is 18.19 CAD. Compared with the current market price of 14.75 CAD, the stock appears Undervalued by 19% .

Intrinsic value calculated using DCF
CA$18.19

Do our valuations actually work? See backtest results .

RX Intrinsic Value
CA$18.19
Undervaluation 19%
Intrinsic Value
Price CA$14.75
Monitor RX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value CA$14.56
Get notified when the price drops into your buy zone
Intrinsic Value CA$18.19
Current Price CA$14.75
Margin of Safety 20% CA$14.56
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about RX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Biosyent Inc.

Explain Valuation
Alternatives to RX

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one RX stock?

The intrinsic value for Biosyent Inc (RX) under the Base Case is 18.19 CAD.

Is RX stock undervalued or overvalued?

Compared with the current market price of 14.75 CAD, the stock appears Undervalued by 19% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett